![]() |
|
| Return to Main Menu | Contact Lenstec |
About Lenstec Lenstec, Inc. is a Florida-based medical device corporation serving the global ophthalmic surgical market, with products currently marketed in more than 50 countries. The company designs, manufacturers and distributes a wide range of intraocular lens (IOL) implants and lens injection systems, and has an established reputation for rapid prototype design and development, and high quality/low cost manufacturing. Founded in 1992, Lenstec currently has offices in Florida and the United Kingdom, and a newly constructed 30,000 sq. ft. manufacturing facility in Barbados, designed by Lenstec to exceed all medical device standards. |
XX | ![]() |
Our proprietary lens manufacturing technologies enable the company to produce premium lenses with reduced variability and improved surgical predictability. In addition, most of the micro-precision lathes, mills, polishing equipment, silicone molds, processing equipment and processes are designed and built in-house by Lenstec’s engineering staff. At Lenstec we continuously strive to improve vision possibilities through research, testing and partnerships with the world’s leading ophthalmologists. We welcome your interest in the company and any questions you may have about our products and services or opportunities to partner with us. Thank you. |
|
||||
| Lenstec has achieved another milestone in its remarkable history with the opening of a newly built and custom designed medical device manufacturing facility in Barbados. After two years of planning and building, the new space is double the size of the previous facility and has the growth capacity to meet expected market demand for the next decade.
Following the move into the new facility and successful completion of environmental and production validations, the factory was certified by British Standards Institution, ensuring a seamless supply of Lenstec products to customers. Lenstec first received the CE Mark in 1997, and currently employs over 120 people in Barbados. As a global manufacturer of intraocular lenses for cataract and |
|
|
refractive surgery, Lenstec’s Barbados-based manufacturing operation currently produces in excess of 300,000 IOLs and other ophthalmic devices per year.
With two IOL designs currently in US clinical trials (The Tetraflex™ presbyopia correcting IOL & the Softec HD™ aberration-neutral IOL) and expected to gain US FDA pre-market approval in 2009, Lenstec projects annual global demand for its lenses to exceed 500,000 after FDA approval. The new facility was designed with the capacity to meet this demand and more. Lenstec Inc. headquarters is located in St. Petersburg, Florida USA. In addition to the manufacturing facility in Barbados, Lenstec also has a sales office in the United Kingdom. |
|
| Lenstec is an ISO 13485 Registered company manufacturing CE Marked products. |